Predictive factors of <sup>18</sup>F-choline PET/CT positivity in patients with prostate cancer recurrence after radiation therapy: is the impact of PSA nadir underestimated?

Johnson, Alison C; Dugué, Audrey Emmanuelle; Silva, Marlon; Moise, Laura; Tillou, Xavier; Joly, Florence; Aide, Nicolas

Predictive factors of ¹⁸F-choline PET/CT positivity in patients with prostate cancer recurrence after radiation therapy: is the impact of PSA nadir underestimated?

Johnson, Alison C; Dugué, Audrey Emmanuelle; Silva, Marlon; Moise, Laura; Tillou, Xavier; Joly, Florence; Aide, Nicolas.

Afiliação

Johnson AC; Department of Oncology, François Baclesse Cancer Center, Caen, France.
Dugué AE; Department of Oncology, François Baclesse Cancer Center, Caen, France.
Silva M; Department of Radiation Therapy, François Baclesse Cancer Center, Caen, France.
Moise L; Department of Oncology, François Baclesse Cancer Center, Caen, France.
Tillou X; Department of Urology, University Hospital of Caen, Caen, France.
Joly F; Department of Oncology, François Baclesse Cancer Center, Caen, France.
Aide N; Department of Nuclear Medicine, University Hospital of Caen, Caen, France. aide-n@chu-caen.fr.

EJNMMI Res ; 6(1): 84, 2016 Dec.

Article em En | MEDLINE | ID: mdl-27873241

Palavras-chave

18F-choline PET; Biochemical recurrence; PSA nadir; Prostate cancer; Radiation therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2016 Tipo de documento: Article País de afiliação: França

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2016 Tipo de documento: Article País de afiliação: França